Has anyone used any SNP analysis pipelines other than the standard variant pipeline? Any suggestions on good ones to try?
Unconfigured Ad
Collapse
X
-
We use most of the libraries from bioconductors.Originally posted by cmm8cmm8 View PostHas anyone used any SNP analysis pipelines other than the standard variant pipeline? Any suggestions on good ones to try?
The Bioconductor project aims to develop and share open source software for precise and repeatable analysis of biological data. We foster an inclusive and collaborative community of developers and data scientists.
Here you will find all possible libraries for several platforms like Affy, Agilent, Illumina..
I hope this helps.
Comment
-
I think there's a confusion here between SNPs for microarray and SNP detection from sequencing. I believe the Bioconductor packages is for the former and the people were asking for the latter.Originally posted by manoj.b View PostWe use most of the libraries from bioconductors.
The Bioconductor project aims to develop and share open source software for precise and repeatable analysis of biological data. We foster an inclusive and collaborative community of developers and data scientists.
Here you will find all possible libraries for several platforms like Affy, Agilent, Illumina..
I hope this helps.
Q: What do you consider as "standard"? Only from the vendors? How about MAQ?
I'm testing NextGENe currently, which is supposedly designed for SNP detection (well, really for mutation detection). Would love to hear what other people use.
Comment
-
For SOLiD data, we use BFAST (admittedly my own aligner) [https://secure.genome.ucla.edu/index.php/BFAST]. The output of that is converted to SAM format (for use with samtools) [http://samtools.sourceforge.net/].
We then use the MAQ consensus model to call SNPs using samtools, modifying the various parameters (train on known data) to get the correct TPR and FPR for calling hets.
Nils
Comment
-
Nilshomer,
I recognize that your data is SOLID, but I was wondering about your method for concensus calling in which you "train on known data" to find the best parameter settings.
I, too, am interested in doing such a thing. I have a 1M SNP Illumina array and Next-Gen data from the Illumina GA2 on the exome. What type of data did you train on?
Which parameters did you find needed the most tweaking?
Did you also find that the number of variants called by MAQ (or Samtools, in your case) was very high? I get >180,000 variants in the cns.filter.snp file when using the parameters from easyrun. This seems like way too many, but I'm having difficulty distinguishing the real things from the false positives.
Looking forward to hearing your input...
Comment
-
We are novice bioinformtacists so use CLC Bio's Genomic Workbench. The DIP (deletion-insertion polymorphism) algorithm works well. The SNP algorithm definitely detects known SNPs and we are optimizing the settings for best sensitivity and specificity. So far if we maximize specificity by looking at the X and Y chromosomes where SNPs should obviously be homozygous for male DNA samples, it reduces sensitivity and we miss too many known SNPs. Relaxing the criteria gives us better sensitivity but we get too many false positives.
Comment
-
I would plot an ROC curve based on all of the parameters in samtools at sites that Illumina genotyped as heterozygous assuming no genotyping error (1/10,000 in actuality). I found varying the "-r" parameter to be of most value. Also, further filtering like requiring a variant to be seen on both strand with sufficient coverage and quality helps a lot. We applied all these methods in our paper (self-publicity).Originally posted by erichpowell View PostNilshomer,
I recognize that your data is SOLID, but I was wondering about your method for concensus calling in which you "train on known data" to find the best parameter settings.
I, too, am interested in doing such a thing. I have a 1M SNP Illumina array and Next-Gen data from the Illumina GA2 on the exome. What type of data did you train on?
Which parameters did you find needed the most tweaking?
Did you also find that the number of variants called by MAQ (or Samtools, in your case) was very high? I get >180,000 variants in the cns.filter.snp file when using the parameters from easyrun. This seems like way too many, but I'm having difficulty distinguishing the real things from the false positives.
Looking forward to hearing your input...
Comment
-
Hi,
Without using LifeTech's BioScope/LifeScope, I think the following pipeline can be applied to SOLiD data for SNP/indel detection.
1) *.csfasta+*.qual / *.XSQ -> SAM/BAM
BFAST, BWA, or NovoalignCS
2) SAM/BAM -> SNP/indel detection
SAM tools or GATK (more accurate)
3) Annotation
GATK or ANNOVAR
I think SAM tools and GATK do not use color-space information to detect SNPs/indels. That is one of the advantage of BioScope/LifeScope.Last edited by HiroMishima; 10-31-2011, 04:44 PM.
Comment
-
I was wondering this, too. Thanks for your information!!Originally posted by HiroMishima View PostHi,
Without using LifeTech's BioScope/LifeScope, I think the following pipeline can be applied to SOLiD data for SNP/indel detection.
1) *.csfasta+*.qual / *.XSQ -> SAM/BAM
BFAST, BWA, or NovoalignCS
2) SAM/BAM -> SNP/indel detection
SAM tools or GATK (more accurate)
3) Annotation
GATK or ANNOVAR
I think SAM tools and GATK do not use color-space information to detect SNPs/indels. That is one of the advantage of BioScope/LifeScope.
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
Today, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 05:39 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
Today, 05:39 AM
|
||
|
Started by SEQadmin2, Yesterday, 09:56 AM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
27 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|
||
|
Started by SEQadmin2, 09-29-2026, 09:51 AM
|
0 responses
77 views
0 reactions
|
Last Post
by SEQadmin2
09-29-2026, 09:51 AM
|
Comment